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PREFACE 
Recently, the author had the opportunity to become 
involved in research in the micronutrient metabolism of 
plants. The interrelations of micronutrient metabolism 
in regard to plant nutrition, growth, and reproduction, 
was a f.ocal point. Although other micronutrients were 
studied, the primary emphasis was placed upon zinc and its 
role in plant growth. 
It has been successfully shown that zinc does play 
a very essential role in plant growth. Since many plant 
and animal enzyme systems are essentially the same, the im-
portance of zinc in the human body in relation to growth, 
function, and the welfare of man, presents unanswered ques-
tions .to me. Among the questions one must examine in 
studying any micronutrient, are; (1) is the element found 
in the body, if so, where, and in what proportions? (2) 
How is the element involved in humans and just what is its 
importance in human metabolic systems? (3) What role is 
played in human disease? (4) How can the element be used 
to alleviate human suffering? 
I propose to answer these questions with respect to 
zinc in an effort to reach some conclusions on the importance 
of this element in human metabolism, 
I wish to acknowledge and thank Doctor Paul Hodgson 
for his help and assistance in the preparation of this thesis, 
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Since man began, he has been vitally interested in 
the effects of the substances which make up his environ-
ment upon his body. Initially, man was interested in food 
or potential food substances. He was concerned whether ex-
cesses or deficiencies of these substances had any influence 
on his he,alth. Later, man became aware that disease pro-
cesses could be related to a variety of identifiable causes 
in which nutrition played a role, and during the past forty 
to fifty years, intense study of the mechanisms of dise,ases 
was focused on the effects of excesses or deficiencies of 
the basic substances, such as mineral elements, vitamins, 
harmones, and enzymes. 
The research in zinc metabolism has roughly paral-
leled man's quest. 
The presence of zinc in muscles and liver was first 
discovered in 1877 (79). However, the need for zinc in human 
nutrition was actually demonstrated only recently. 
Early indications for a biologic function for zinc 
may be given by citation of the early literature on the 
effects of zinc; Raulin, in 1869, proved zinc was a neces-
sary nutrient to Aspergillus niger (80). Mendel and Bradley 
in 1906, produced evidence that zinc was an essential con-
stituent of the respiratory pigment of the snail, Sycotypus, 
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analogous to the hemocyanins (56). In 1919, Delezene re-
ported a very high concentration of zinc in snake venom, 
and then showed it to be in a stable combination with the 
intensity of the venom action directly proportional to the 
concentration of zinc (13). Conclusive evidence of the 
essential nature of zinc in the rat diet was produced in 
1934 by Todd and co-workers (94). 
Although conclusive evidence of the zinc requirement 
for man and higher animals was not proven until recently, 
Keilin and Mann in 1939, showed zinc to be present in the 
prosthetic group. of the enzyme carbonic anhydrase and sug-
gested tha zinc. must be required in nutrition because of 
the wide p 
species (4 ). 
of carbonic anhydrase in many animal 
CHAPTER II 
ZI C IN BODY TISSUES, ORGANS, AND FLUIDS 
1. Whole Body 
The total body zinc stores in the average adult human 
ranges between 1.2 and 3 grams. This is about one half the 
biologic store of iron, 10-15 times the store of copper and 
40 times th t of iodine. The amount of zinc supplied by an 
average daily diet is approximately 10-15 mg, but, as is the 
case of most orally ingested substances, the fraction actu-
ally absorbed from the intestinal tract is influenced by 
numerous physiologic mechanisms (96, 48, 103). 
Apparently, there is little. if any, evidence of 
appreciable storage of zinc by the fetus, as occurs with 
iron and copper. The concentration of zinc in the human 
fetus changes little throughout fetal life and the liver 
and spleen together always contain approximately the same 
proportion (roughly one-quarter) of the tota.l zinc (Ill). 
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Newborn and very young mammals seem to be more vari-
able than adults in zinc content and tend to contain some-
what lower, or similar, concentrations of the element at 
birth and ma turi ty. However, the value.s given in the 
literature for some newborn animals (cat, guinea pig, rabbit) 
may be abnormally high if one considers the increased amount 
of hair on these animals in comparison to mouse, rat, and 
human values. Hair and fur contain much higher concentra-
tions of zinc than almost all other body tissues. 
The normal range of zinc concentration in the human 
body has been estimated by various authors to be 15 to 60. 
parts per million and depending upon the method used, various 
values may be quoted for zinc content of a particular tissue. 
The ubiquitous nature of zinc, in addition to the relatively 
insensitive methods of zinc analysis up until recent years, 
has probably accounted for this great variation o.f quanti ta-
tive values seen for zinc levels in tissues. 
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2. Tissue Distribution 
Isotopic zinc studies seem to demonstrate a continual 
tissue deposition and turnover of zinc which varies greatly 
with different tissues. Zinc-65 injected into the body has 
the highest turnover rate in pancreas, liver, kidney, pitui-
tary, and adrenal glands. Muscle, erythrocytes. brain and 
testes exchange zinc less rapidly, whereas zinc is deposited 
in the skeleton and teeth relatively slowly, but, found for 
relatively long periods of time. Zinc deposited in hair 
remains there until the hair is shed. 
In terms of absolute. concentrations, the pigmented 
tissues of the eyes, hair. and bones " carry far higher con-
centrations of zinc than other body tissues and organs. 
3. Eye Structures 
Tissues of the eye contain large quantities of zinc. 
Vallee has compiled a large number of references into a 
survey of species of vertebrates which no only indicates 
marked species differences. but marked differences in the 
zinc distribution within a single eye (l03). The zinc con-
tent of lens and aqueous humor is not remarkable in any 
species, but the choroid and. retina seem to have outstand-
ingly high values in most cases. Probably the highest known 
concentration of zinc in living matter occurs in the melanin-
pigmented tissues of the eyes of some fresh water fishes 
(trout, perch). The pigment-protein couplex constituted 
41.6% of the dry weight of the perch choroid, accounting 
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for 74% of the zinc content of this tissue (6). 
As stated above, species and individual differences 
exist, but the various eye tissues can be placed in the same 
order in respect to zinc concentrations in each of the species 
examined. This order, in descending concentrations of zinc. 
is as follows: Iris, choroid (plus pigment epithelium), 
retina (minus pigment epithelium), lens, aqueous and vi-
treous humor, sclera, cornea, and optic nerve (6)". 
The eyes of colored and albino rabbits were studied. 
Zinc levels of 127 and 466 P.P.M. were found in the iris and 
choroid respectively of the colored animals. compared with 
54 and 86 P.P.M. for these tissues in the albinos (7). 
The intravenous injection of 100 mg/kg body wt. of 
di thiopheny lcarbaz.one, ache la ting agent of z inc and 0 ther 
metals, causes blindness in dogs within 24 hours due to in-
activation of zinc by chelation (103). 
It has been shown by Bliss that horse liver alcohol 
dehydrozenase can catalyze the redox interconversion of Vita-
min Ai alcohol and aldehyde, In the retina, this reaction is 
catalyzed by retenue reductase which indicates this may be 
identical or similar to alcohol dehydrogenase (5). 
4. Epidermal Structures 
Although zinc has been found in essentially all body 
tissues, a preponderant 15 to 20% of the total body stores 
is concentrated within the skin and its accessory structures(31). 
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What useful function zinc plays in these tissues is yet un-
known, but as will be pointed out later, a definite function 
of zinc in the skin is indicated beyond that of being a 
simple storage reservoir. 
In beriberi, a thiamine deficiency, a marked decrease 
of zinc concentrations was observed in blood, hair, skin, and 
nails (87). Eggleton also produced evidence of an interest-
ing correspondance between beriberi and the zinc concentration 
of human epidermal structures. Subnormal levels of zinc were 
found in hair, nails, and skin of beriberi patients. Essen-
tially, the values for zinc are one half of the levels found 
in corresponding epidermal structures (16). 
Various authors working with zinc deficient dietary 
regimens have described skin hair, hoof' or mucosal disorders 
in a variety of animals. Barney described a parakeratosis 
of tongue mucosa to be a unique pathologic lesion in zinc 
deficient monkeys (2). Mills in Britain has described, among 
other manifestations of zinc deficiency response, alopecia, 
hyperkeratosis of skin in areas of hair loss, a coarsening 
of wool or hair growth and alterations in the structural 
growth of hooves in both lambs and calves (59). 
Day. also Prasad, working with rats, has described 
similar hair coat and skin changes in that animal after being 
placed on a zinc deficient diet (12, 78). A similar type of 
skin lesion termed "parakeratosis" has been studied, described 
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and treated in pigs in the U.S. since the 1940's (43. 95). 
Reinhold and his fellow workers studying nutrition 
in rural Iranian villages in the vicinity o.f Shiraz, a re-
gion in which the occurrence of zinc deficiency has been 
previously observed in humans, found zinc concentrations of 
hair to be significantly lower in village residents than in 
similar control population in Shiraz. Village diets con-
sisted predominately of flat bread prepared from locally 
grown cereal grains, other. locally grown .vegetables and 
relatively little animal protein. City diets were deversi~ 
fied and abundant in fruits, vegetables, and meats brought 
from widely spread localities (81). 
Although zinc concentrations in hair was signifi-
cantly lower than those in controls, values for copper and 
nitrogen concentrations did not differ between the two groups. 
This fact that there was no difference in copper and nitro-
gen values indicates that the dietary insufficiency probably 
is not due to decreased protein intake (81). 
Lowest zinc concentrations occurred in the village 
women. Results of these studies provide evidence that con-
centrations of zinc in human tissues may be depleted, pre-
sumably as a result of limited intake (or decreased absorp-
tion) and possibly increased losses of zinc (as in child-
bearing and lactating women) (81). 
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5. Male Genital Tissues 
Zinc concentrations of 1-2 mg per gram of dried human 
semen have been reported (54). Differences between sperm 
and semen plasma were considered insignificant, though a 
variable but significant percentage of seminal plasma zinc 
was found to be dialyzable. 
Zinc concentration in the human testes have been vari-
ably reported, but are, in general, higher than zinc levels 
in other body tissues, except eye tissues. 
Saito et al recently studied the zinc content of sperm 
taken from various levels of the dog reproductive tract, simi-
lar to the previous study done in rats by Birnbaum (83, 4). 
"Preprostatic" zinc levels were determined on sperm taken 
from dog testes, epididymis and vas. .Canine ejaculate sperm 
zinc and canine seminal zinc determinations were also made. 
The latter value was 1.75 mgZn/g dry wt. The results (see 
table 1.) indicate essentially no zinc uptake by sperm in the 
dog until after the sperm have passed through the prostate 
and have been bathed by the prostatic secretions. This would 
seem to indicate that a function of the dog prostate is to 
contribute zinc to the spermatozoa, In the rat, the zinc con-
tent (0.86 mg Zn/g dry wt.) of spermatozoa from the epididymis 
is similar to the level reported (by Birnbaum) in ejaculated 
spermatozoa {O.89 mg Z.n/g dry wt.} the determinations being 
made by similar and comparable methods. However, Birnbaum, 










COMPARISON ZINC LEVELS IN SPERM OF TWO SPECIES 
TAKEN FROM VARIOUS LEVELS OF THE 
REPRODUCTIVE TRACT 
Testes Epididymis Vas 
O.l5 0.16 0.18 




NOTE: All values are milligrams zinc per gram dry weight. 
10. 
at a much earlier location in the rat reproductive tract, 
possibly beginning within the testes itself. It is obvious 
that preprostatic canine spermatozoa contain much less zinc 
than the corresponding preprostatic rat spermatozoa. In the 
rat, epididymal and vasal spermatozoa are rich in zinc and 
the prostatic fluid constitutes only a small part of the 
ejaculate. In the dog, on the other hand, preprostatic 
spermatozoa are extremely poor in zinc and the bulk of the 
ejaculate consists of prostatic fluid rich in zinc. These 
facts present evidence consistent with the hypothesis that 
there is a biological need for zinc in the spermatozoa and 
that, in the dog. it is a. function of the prostate to supply 
this need. In the rat, apparently. the spermatozoa do not 
have to depend on the .prostate to supply their zinc require-
ments. Although high levels of zinc are present, Gunn et al 
have demonstrated that the prostate is .not necessary for 
fertility and fecundity in the rat species (51, 26). Since, 
in the dog, it has been presumably shown that the greater 
part of the zinc which is acquired by the spermatozoa is 
contributed by the prostate, it should now be shown whether 
this prostatic function is or is not essential to fertility 
or fecundity in this species~ Similar studies, such as the 
above, have not been done in the human species to date~ 
Values for prostate gland concentrations of zinc in 
general tend to run very high. Depending upon the investi-
gator, values range from 102 mg Zn/g dry wt. to 859 mg Z,n/g 
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dry wt. (17, 53). 
The activity of seminal carbonic anhydrase simultan-
eously increases with the zinc content, however, the amount 
of enzyme calculated to be present only accounts for 3.5 
percent of the total zinc present (52). Thus, though car-
bonic anhydrase is present in human semen, its activity is 
insignificant and can not account for the high zinc content 
in semen (102. mg Zn .per g dry wt. human sem.en (103). 
Neither acid or alkaline phosphatase activities appear to 
be related to zinc content (21, 33). 
6. Blood 
Whole Blood. Various investigators report zinc values 
in whole blood to range from 300 ug to 1500 ug Zn/lOO cc 
(66, 98, 105). Plasma values range between 80 ug and 390 
ug/lOO cc while red blood cell concentration are reported 
to be between 690 ug and 1440 ug/lOO cc. Should one desire 
to ~alc\1la te percentages; 75 to 85 % of the whole blood zinc 
is contained in erythrocytes, 12 to 22% is contained in serum 
and 3% is contained in the leukocytes (96, 103). However, 
the individual leukocyte contains 25 times as much zinc as 
does the individual erythrocyte (98). 
Erythrocytes and Carbonic Anhydrase. Under normal 
conditions, the entire zinc content in erythrocytes can be 
accounted for as carbonic anhydrase (36). In 1940, Keilin 
and Mann reported that the newly isolated, purified 
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erythrocyte carbonic anhydrase molecule contained 0.33% zinc 
(42). Carbonic anhydrase is a zinc metalloenzyme that re-
versibly catalizes the hydration of carbon dioxide to bicar-
bonate and hydrogen ions according to the following equations 
(14) : 
carbonic 
C02 + H20 rnhydras~ H~ ~~COJ~ 
The enzyme is found in red blood cells, kidney, gas-
tric mucosa and to a lesser extent, the central nervous 
system, lungs, pancreas and salivary glands (11). 
In most normal persons and patients with anemias; 
(except pernicious anemia) polycythemia vera, secondary 
polycythemia, leUkemia and congestive heart failure, both 
erythrocyte zinc levels and carbonic anhydrase activity are 
lowered in parallel fashion, so that the decreases are pro-
portional to the decreases in hematocrit, hemoglobin levels, 
and erythrocyte counts. In p~cious anemias, the erythro-
cyte zinc concentration and carbonic anhydrase activity 
remain nearly normal, although hematocrit, erythrocyte 
count and hemoglobin levels are markedly decreased. Thus 
zinc and enzyme values per unit of R.B.C •• remain in the 
normal range in the diseases listed above, whereas, in perni-
cious anemia, the zinc and enzyme values per unit of R.B.C. 
are significantly elevated above normal. A similar type re-
lationship exists in sickle cell anemia (99). 
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Leukocytes. Zinc has been thought to be associated 
with the granules of polymorphonuclear and eosinophil cells, 
the eosinophils containing 10times more zinc . than do other 
leukocytes (55). Indeed, a protein containing 0.3% zinc per 
gram dry weight has been isolated from human leukocytes. 
This zinc protein is responsible for 80% of all the zinc 
found in human leukocytes and is differentiated clearly from 
carbonic anhydrase. While the protein is presumably an en-
zyme, the nature of its enzymatic activity is not known (34). 
Fihl and co-workers proved zinc to be the principal 
metal in the granules of eosinophilic granulocytes, and also 
in the eosinophilic granules of peritoneal mast cells (69. 
68). They postulated that the metal. may be related to zinc-
dependent enzymes like dehydrogenases, amino-peptidase, and 
phosphotases which occur in eosinophil granules and also in 
neutrophils and mononuclear leukocytes. An alternative ex-
planation suggested by Mashe would be that zinc here, as in 
the islets of Langerhans, may have a stabilizing effect on 
some specific protein (50). 
Serum 2!: Plasma. 
yet been well studied. 
The role of zinc in plasma has not 
It would seem quite probable that 
zinc becomes bound into zinc-protein complexe.s and metallo-
enzymes. What is not excreted or removed from circulation 
by passage into intracellular compartments. becomes a large 
pool of readily exchangeable zinc. 
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"Firmly" and "loosely" bound moieties are present in 
all serum protein fractions, ,though zinc seems most strongly 
bound to the globulins (112). Others have felt that a ma-
jority of the zinc is loosely bound to albumin and carried 
in this fashion (103). 
Himmelhoch recently discovered three, hithertofore, 
new unknown serum zinc proteins. These seem to be "firmly" 
bound zinc-protein complexes that do not overlap the chroma-
tographic acti vi.ty profiles of .some other zinc-protein com-
plexes found in serum; lactic and dehydrogenase, alkaline 
phosphatase, carboxypeptidase and glutamic dehydrogenase. 
These proteins have not yet been c.hara.cterized (32). 
Eminians and others, have suggested normal zinc levels 
in serum or plasma to be in the range of 90 to 120 pg/100 cc 
(17, 103). As will be brought out later in this discussion, 
a great variety of diseases tend to affect the serum zinc. 
either increasing or decreasing the levels from the normal. 
78 Milk 
In cows, the concentration of zinc in milk (3-5 mg/L) 
is about 10 times greater than that of iron, 100 times greater 
than that of copper, iodine and manganese, and 1000 times 
greater than that of cobalt. Similar dif,ferences may be 
found in human milk (96). Colostrum, in all species studied, 
contains 3 to 5 times the amount of zinc that is found in 
later true milk. Values as high as 20 mg Zn/L have been 
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observed in humans at the time of delivery. The zinc level 
then returns slowly to the normal value (3-5 mg/L) over a 
6 month period (3). 
Nishimura easily demonstrated zinc deficiency in 
baby mice, simply by exclusion of. zinc-rich colostrum from 
their diets by fostering them at birth with mothers at later 
stages of lactation. Newborn mice nursed by their own 
mothers for 2*-4 days before transfer to foster mothers, 
grew normally, whereas newborn mice that were fed, for 
periods of 3-5 days by foster mothers that had been lactat-
ing 13 -18 days, and were .then re turne d to the ir own mo thers • 
usually develope.d disorders somewhat typical of zinc defi-
ciency which could be prevented by, .or which responded to, 
oral administrations of zinc (63). This phenomenon has not 
yet been studied in humans. 
8. Urine 
In consideration of the urine zinc levels and the 
normal kidney blood perfusion, one could postulate a rather 
efficient system of tubular reabsorption of zinc. Normal 
individuals excrete in the urine, relatively small amounts 
of zinc daily (0.1-0.9 mg/day) (96). Significant zincuria 
may occur in; Albuminuria, average 2.l mg Zn/24 hr (20), post-
alcoholic cirrhosis, average 1.0 mg Zn/24 hr (101), post-
operative period, range 2.8 mg Zn/24 hr initially to 1.3 mg 
Zn/24 hr on day 20 (31). 
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9. Bone 
Early researchers felt that zinc resembles lead and 
nickel in its tendency to accumulate in the bones, and they 
reported relatively high values of zinc for bones and teeth 
(150.250 ppm) (9, 15, 49). 
Day and McCollum in 1940, while studying zinc defi-
ciency in the rat, found a reduction in the proliferative 
activity of cartilage cells and a decrease in .osteoblastic 
activity, as manifested by a decrease in metaphyseal bone 
benea th the cartilage plate (12) ~ Prasad, in his initial 
study of apparent zinc deficiency. in human males, found 
dwarfism to be a .part of the clinical picture (72). Zinc 
is in some way bound to the initiation of. mineralization of 
preosseous tissue and is progressively incorporated within 
the preosseous tissue as mineralization occurs and it is 
still present in fully calcified .tissue. On the basis of 
zinc-65 and biochemical studies, it can be saia that zinc is 
literally sequestered in calcified bone and masked for histo-
chemistry and is not available for ionic exchange. It has 
been postulated that zinc helps to catalyze the calcification 
process and therefore, is essential to the growth or metabo-
lism of bone though the mechanism has not been established 
(30) '. 
10. Liver and Pancreas 
Zinc, unlike iron and copper, is not normally stored 
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in large amounts in the liver, in fact, studies with zinc-
65 indicate a rapid deposition and high turnover rate in 
liver, pancreas, kidney, pituitary and adrenals. However, 
eax-lier studies have indicated that both liver and pancreas 
contain approximately twice the amount of zinc contained in 
other body. tissues (67). This seems to. be controversial. 
Excretion of absorbed zinc. from the body largely in 
the feces. is thought to be mainly by way of the pancreatic 
secretions which contain a quite high concentration of zinc, 
probably due to the pancreatic zinc metalloenzyme, carboxy-
peptidase (103. 58). It has been shown by radioactive zinc 
studies, that the zinc-65 content of bile is very low (58). 
Much early research has been carried on with the pan-
creas and zinc metabolism due to the once thought possibility 
of a zinc - insulin interrelationship holding the key to 
diabetes alleviation (103). However. this ha.s largely been 
disproven now. 
11. Sweat 
Prasad and his co-workers, in a study from Egypt, 
found the zinc content of Whole sweat to be 115 ± 30 mg% 
and that of cell-free sweat to be 93 ± 26 mg%. Thus, in a 
hot climate where sweating can be excessive, one may lose up 
to 2 to .3 mg of zinc per day (75). This is thought to be 
one of the mechanisms causing zinc deficiency in humans. 
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CHAPTER III 
ZINC DEFICIENCY IN HUMANS 
1. Etiology and Manifestations of Zinc Deficiency 
Up until 1961, when Prasad and eo-workers reported 
on their work in Shiraz, Iran, the possibility of zinc defi-
ciency states in humans had not been. widely considered. As 
previously stated, Eggleton produced evidence of subnormal 
zinc levels in epidermal .structures in beriberi sufferers, 
however,.this was not considered to be zinc deficiency per 
se (16). Zinc deficiency. as found in Iran and later seen 
similarly in Egypt, was manifested. by what appeared to be a 
severe iron deficiency anemia in conjunction with arrested 
growth, hepatosplenomegaly and hypogonadism in young male 
adults (73, 74). 
The conclusion that .these patients were manifesting 
zinc deficiency is based upon the following.: (a) the zinc 
concentrations in plasma •. red blood 0_11s and hair were de-
creased as compared. to normal subjects: (b) the excretion 
of zinc il'l urine and sweat was decreased; (c) the radioactive 
zinc-65 stUdies which reve.aled that the plasma zinc-turnover 
rate was greater in the patients. the 24-hour exchangeable 
pool was smaller, and the excretion of zinc-65 in stool and 
urine was less in the dwarfs than the control subjects (74). 
The possible factors responsible for zinc deficiency 
in these subjects are several, (1) Poor availability of zinc 
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from the diet normally consumed in the villages of Iran and 
Egypt; either low content of zinc or zinc being complexed 
by high levels of phytate in the bread .and beans of the diet~ 
Phytate being a strong complexer o.f zinc. (2) Blood loss 
caused by hookWorm Dr schistosomiasis infestation. () zinc 
lost by excessive sweating ('74) • 
. The anemia in all cases was hypochromic, microcytic 
in type and related to iron. deficiency .and was completely 
corrected .by oral administration of. iron salts. However, 
the administration of iron salts did. not. correct the hepato-
splenomegaly or alleviate the growth. retardation or hypo-
gonadism~ This. would seem to indicate seve.re anemia and 
iron deficiency are not necessary factors for growth re-
tarda tion and hypog.onadtsm ('76) •.. 
No evidence for dei'i.c.iency of other essential trace 
elements or vitamins were obtained ('76). 
In all cases, following treatment with zinc, the size 
of the liver and spleen decreased markedly. The rate of 
growth increased and was greater in patients who received 
supplemental zinc as compared to those who received iron. in-
stead or just plain hospital diets. Pubic hair appeared in 
all cases within '7-12 weeks after zinc supplementation was 
started. The genitalia size became normal and secondary 
sexual characteristics developed within 12-24 weeks in all 
cases which received zinc. On the other hand, no such changes 
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were observed in the iron supplemented group or on hospital 
diet alone in the comparable length of time. Two dwarfs 
which refused to take part in the study were followed in 
their villages for 1 year. They failed to grow or show any 
changes in their sexual development (76). 
Liver function tests were all unremarkable, except 
for the serum alkaline phosphota.se which increased to normal 
levels following treatment (73). 
2. Absorption and Excretion 
Like iron, zinc appears to be absorbed only to a 
limited extent from the intestine •. Studies using zinc-65 
have shown that only 5 to 10% of dietary zinc is absorbed 
at a normal intake level (67). Since the average well 
balanced human diet supplies 10 to 15 mg. of zinc per day, 
the daily intestinal.absorption has been estimated to be 
0.5 to 1.5 mg zinc per 24 hour period (19). The site of 
absorption of zinc from the intestine and the mechanisms 
involved are not understood at the .. present time (67). No 
specific plasma protein has been definitely identified as 
a transport protein for zinc, as is true in the case of 
iron (transferrin). and. of copper (ceruloplasmin), but 
some think that zinc may combine with thep globulin, trans-
ferrin, noncompetitively with iron and thus this protein 
be responsible for the transport of both iron and zinc in 
the body (106). 
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O'Dell and Savage have shown that phytic acid, found 
at high levels in some grains and vegetables, decreases the 
absorption of zinc similar to its effect on the absorption 
of iron (65, 64). Also, high levels of calcium and phos-
phate have been reported to inhibit intestinal absorption 
of zinc~ Geophagia or clay eating, (clay containing increased 
levels of phosphate) has been suggested as one of the contri-
butory factors in .the patients described from Shiraz in 
1961 (73). The pH of the diet, or of the intestinal tract, 
or both, may also influence the availability of zinc (60). 
Most of the zinc intake is excreted unabsorbed in the 
stool, chiefly, as stated above, in the pancreatic secretions 
and a small amount in the bile (61). .compared with the 
amounts ingested, the amount of zinc excreted in the urine 
of normal individuals are exceedingly small, on the order of 
0.1-0.9 mg. per day. Zinc excretion appears to be independent 
of the urinary vo lume (34 L However. as will be taken up 
later, urinary zinc le.vels may be quite elevated in certain 
disease states. 
3. Endocrine Manifestations 
Sandstead and his co-workers (84, 85), working with 
Egyptian dwarfs, apparently zinc deficient, similar to those 
reported upon by Prasad (74, 75), masterfully studied with 
rather involved research, the endocrine manifestations of 
those dwarfs. 
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Noting that zinc apparently concentrates to some ex-
tent in the pituitary (45). and that pituitary gonadotro-
pin (57) and corticotropin (35) are apparently augmented by 
zinc in eXperimental animals, and observing some of the 
cardinal manifestations of panhypopituitarism in the dwarfs, 
(arrested growth and osseous development though normally 
proportioned bodies, hypogonadism,-depressed ACTH production, 
and increased sensitivity to insulin). they studied various 
pa~meters of endocrine function. in these dwarfs (29)8 
Linear growth, bone age, thyroid function, glucose 
tolerance, pituitary corticotropin.reserve, adrenal corti-
cal function and pituitary gonadotropin excretion were eval-
uated by standard techniques. 
Each child, after preliminary evaluation, was treated 
either by diet alone or with supplementation of either iron 
(1 gm/day) or zinc (90 mg/day) and. followed for a long per-
iod of time. Controls were included Which used their normal 
diet, but with or without supplementation with iron or zinc. 
Patients receiving iron gained in height, but the in-
crease was not as striking as the growth acceleration in 
those receiving zinc. Two patients originally given iron 
were subsequently given zinc and an additional growth in-
crease occurred. The plasma zinc concentration of these 
patients receiving iron approached normal, (the zinc source 
presumably the diet), though in some cases the serum iron 
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concentration remained low. The zinc supplemented group had 
a growth acceleration despite the continued presence of low 
hemoglobin and serum iron concentrations. Neither of the 
two village controls who received no micronutrient therapy. 
grew during the observation period (greater than 300 days). 
Overt hypothroidism was not present and the pitui-
tary-thyroid interactions were generally normal. The major-
ity had normal PBI's and normal to elevated 24 hr RAT up-
takes. Serum cholesterol was low. 
Liver function tests were normal in nearly all 
patients, and liver biopsies were done, though there was no 
evidence grossly or microscopically of fat malabsorption. 
The D-xylose absorption test was normal. 
A variety of abnormal curve.s were obtained in the 
oral glucose tolerance test with the majority of patients 
having an apparent delayed absorption of glucose. Rela-
tively prolonged elevations in blood sugar occurred in others. 
Intravenous glucose tolerance tests were normal to 
slightly accelerated in nearly all patients indicating ade-
quate insulin production. Three out of the four patients 
tested, using the Engel-Scott insulin-glucose test (18), 
showed striking intolerance to intravenous insulin (0.1 units 
regular insulin/Kg bOdy weight) requiring termination of the 
test but indicating hypopituitarism in these patients. 
The responses to exogenous adrenocorticotropin (AOTH) 
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and Metopyrone infusion test were frequently abnormal. The 
mean basal 17-hydroxysteroid (17-0HS) excretion was 6.24 ± 
2.6 mg/24 hre After ACTH stimulation, (40 units IV in D5W, 
given over 8 hours, beginning between 8 and 10 A.M. on 3 
consecutive days), the rise in urinary 17-0HS was frequently 
delayed, or following an initial rise, there was a fallon 
successive days. These findings suggested a decreased adrenal 
reserve, possibly secondary to decreased ACTH production or 
release. 
The excretion of l7-0HS following the Metopyrone in-
fusion test was subnormal in the majority of patients, both 
in terms of absolute rise in 17-0HS excretion and in compari-
son to the ACTH response. 
The responses to intravenous Metopyrone coupled with 
the ACTH tests suggest the presence of limited pituitary 
ACTH reserve. 
After periods of treatment with zinc. iron, or diet, 
the pituitary-adrenal axis was re-evaluated, in six patients, 
and showed an improved response to ACTH in four patients, but 
the response to Metoyrone infusion improved in only one. Al-
though the member of observations were too small to obtain 
valid conclusions as to the cause of. improvement, their data 
suggested that increased response from A.CTH and Metopyrone 
was associated with improved zinc nutrition and was not de-
pendent upon iron. 
---
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Hypogonadism in the group of patients was manifested 
by absence of pubic, axillary or facial hairs, a small penis 
and atrophic testes (prepuberant sexual development). Uri-
nary pituitary gonadotx'opins al'ld_ l?-Ketosteriods were low 
in all patients with the average l?-Ketosteriod excretion 
for the group approximating the normal level for eleven year 
old children. 
Diet and iron therapy were followed by slow matura-
tional changes •. In contrast, treatment with zinc was fol-
lowed by. surpr.isingly accelerated sexual maturation. In 
some, pigmented.pubic,extremity, and facial hair appeared 
within J weeks of beginning of zinc treatment and matura-
tional changes in the penis and. scrotum could be seen. 
Early growth of pubic and lip. hair was followed by an in-
crease in genital size. the grow.th. of additional facial, 
extremity, pubic, and finally. axillary hair. Urinary ex-
cretion of pituitary gonadotropin also became normal in 
some patients. The two untreated control patients remaining 
in the village, did not show change in genital site or de-
velopment of secondary sexual characteristics during the 
observation period of greater than 1 year. 
The endocrine abnormalities in this group of patients 
are compatible with hypopituitarism. In this group, growth 
failure and hypogonadism are the most outs.tanding features, 
but also, decreased pituitary ACTH reserve and an abnormal 
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oral glucose tolerance have been found. Here, hypothroidism 
did not appear to be. an obvious problem, however, the thyroid 
studies did suggest iodine deficiency in .some cases. 
Zinc therapy caused an improvement in these clinical 
fea tures and apparently induced puberty. .Di.et and iron 
therapy alone, while tending to alleviate somewhat, did not 
bring about a marked improvement in the symptoms. 
It. is .probably still a little.soon to denote a cause 
and effect relationship between zinc de.£iciency and hypopi-
tuitarism, since all.the evidence is not yet in, but indica-
tions and evidence is certainly in that direction. 
CHAPTER IV 
BIOCHEMICAL ASPECTS OF ZINC METABOLISM 
1. Zinc Metalloenzymes 
Continued research in the past few years seems to 
make it clearer that most micronutrients function through 
their relationship with enzymes, hormones, nucleic acids, 
and other proteins. Although zinc has been studied in liv-
ing organisms for many years, it has only been recently 
that one can presume the manner of zinc participates in 
metabolism. Its relationship with enzymes has been a center 
of recent biochemical research in the. field. 
Although Keilin and Mann report,ed the isolation of 
carbonic anhydrase in 1939, it has only been recently that 
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the impetus of study has mushroomed into the discovery of 
some twenty zinc-containing metalloenzymes from a great 
variety of species. This would seem to indicate an overall 
importance of this element in metabolism (93). See Table (2). 
"The zinc atoms in these molecules are specifically 
and firmly incorporated into the protein such that they can 
be thought of as a single physical entity in their native 
state. Thus, during isolation of the enzyme, the ratio of 
zinc to protein rises to a fixed. limit, as does the ratio 
of activity to protein. As.a result, the ratio of zinc to 
activity also reaches a fixed limit, while the ratio of the 
sum of all other metals to activity simultaneously approaches 
zero. With complete purification, the number of gram atoms 
of zinc per mole of apoenzyme is an integral value, attesting 
to the specificity of the association and implying stoichio-
metry. The concomitant rise of zinc with activity suggests 
that the. metal is specifically and critically related to 
enzymatic function. In this regard, these characteristics 
of zinc metalloenzymes contrast with those of zinc-metal-pro-
tein complexes, a large group of enzymes which may require 
zinc as one of several metals for activity, but which cannot 
be isolated with a metal in situ, due to the weaker and less 
specific association between it and the protein (104)". 
Carbonic Anhydrase. First repor.te.d as a CO2-protein 















































organisms including plants. cattle, sheep, and humans. In 
erythrocytes, it acts as a catalyst to mediate CO2 excre-
tion from the body. It is thought to have a molecular 
weight of 30,000 and contains a zinc concentration ranging 
from 0.2% to 0.3% depending upon its source. The chemical 
details of the bonding between. zinc and the protein are not 
known, neither also is. the mechanism of its action known (103). 
Alkaline Phosphotase. This e.nzyme has been isolated 
from kidney, E. coli; and human leuk.ocytes. It is thought 
to contain 0.15% of firmly bond zinc with several metal 
binding sites per each molecule enzyme (103). Prasad found 
depressed levels of alkaline phospha.tase .which reverted to 
normal by zinc supplementation (73). 
Lactic Dehydrogenase. Apparently an NAD-dependent 
enzyme. first isolated from rabbit skeletal muscle, this en-
zyme has not been completely characterized but seems to 
catalyze the redox interconversion of lactic and pyruvic 
acids (103). 
Glutamate Dehydrogenase. Also a NAD-dependent enzyme, 
this enzyme is different from other dehydrozenases by not 
acting on primary or secondary alcoholic groups, but which 
catalyzes the reversible oxidative deamination of an amino 
acid. It is thought to have a molecular weight of 1,000,000; 
a much larger molecule than other pyridine nucleotide-depend-
ent enzymes (103). 
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Carboxypeptidase. First purified from pancreatic 
juice, this enzyme has a molecular weight of 34,000. Each 
molecule contains one atom of zinc. When zinc is removed 
from the enzyme, activity is lost in direct proportion. 
Readdition of zinc ions fully restored activity (102, 103). 
Its main function is to catalyze the hydrolysis of 
carboxy terminal peptide bonds in proteins and peptides. 
but it also hydrolyzes esters. While enzymatic activity may 
be resotred to the apoenzyme in varying degrees by the addi-
tion of other metals, these metals do not give the complete 
spectrum of specificity of action that is attained by the 
native zinc enzyme (93). 
Hsu, studying zinc deficiency in rats, reported that 
it caused decreased activity of pancreatic carboxypeptidase 
B or liver alcohol dehydrogenase. The observed reduction of 
enzymic activity may be related to poor proteolysis in the 
intestinal tract and therefore, poor utilization of feed 
which occurs in zinc deficient rats (37). 
Alcohol pehydrogenase. Isolated from yeast as early 
as 1937. this enzyme has also been found in liver of various 
species, and is thought to present zinc atoms as an active 
enzymatic site with an unexplained interaction between NAD 
and alcohol dehydrogenase. Thus, this enzyme also is appar-
ently a NAD-dependent enzyme whose concentration and, or, 
activity varies directly with the activity of NAD (10,3). 
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One function that has been studied is the conversion 
of vitamin A alcohol to vitamin A aldehyde in the process 
of vision. The essentiallity of zinc to this enzyme can be 
seen, as mentioned earlier, by causing blindness in dogs due 
to binding of zinc by chelating agents. 
Evidence seems to indicate formation of enzyme-coen-
zyme-substrate complex with the zinc atom functioning at or 
in close proximity to the active site on the enzyme molecule 
(93) • 
28 Zinc-Enzyme Complexes 
In addition to being a necessary constituent of a 
number of metalloenzymes, zinc functions as a co-factor, 
apparently increaSing in some nonspecific manner the acti-
vity of a number of other enzymes. These include arginase, 
carnosinase i> .leci thinase, eno.lase, aldolase, ozaloacetic 
decarboxylase, alkaline phosphatase, histidine deaminase and 
a number of. mono-, di-, and tri-peptidases (103, 93). 
CHAPTER V 
ZINC RESEARCH IN DISEASE PROCESSES 
Current literature is beginning to show important and 
significant reports of promising research on zinc as it is 
related to disease processes and basic cellular metabolism. 
These will be briefly summarized. 
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1. Post-Alcoholic Cirrhosis and Hepatitis 
It has been previously stated that zinc is an essen-
tial component oi' several hepatic enzymes, including glutamic 
and alcohol dehydrogenases. Several investigators (103, 106, 
23) have reported a decrease in serum zinc levels in patients 
with post-alcoholic cirrhosis. Vallee (lOJ) reported abnor-
mally high urinary zinc excretion in these patients, in the 
order 1000 ± 200 ug per 24/hrs. The. abnormal variance of zinc 
levels in these patients tends to. correlate positively with 
the severity of the disease. Liv.er tissue zinc concentrations 
were decreased below normal levels. 
Since zinc is an essential component of the enzyme, 
liver alcohol dehydrogenase, and therefore, participates in 
the oxidation of alcohol, and since ethanol is considered to 
have an etiologic role in thedevelo.pment of Laennec's cirr-
hosis, it. follows that low zinc levels in the body may play 
some role in the development of alcoholic cirrhosis. This 
has been substantiated by Vallee (103) to the extent that 
the oral administration of zinc quickly resolves these ab-
normalities of zinc metabolism thus suggesting a "condi-
tioned" zinc deficiency, and producing a tendency toward 
restoration of normal liver function. Whether or not this 
also produces a reversal or termination of the cirrhotic 
process'_has not as yet been determined or substantiated. 
It has been suggested by studies that following alcohol 
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ingestion, the serum zinc concentration decreases (91). 
Similar results have been reproduced by Kahn and co-workers, 
in carbon tetrachloride induced liver cirrhosis of rats (40)~ 
It has been proposed that high blood levels of alco-
hol could deminish the. activity of zinc containing alcohol 
dehydrogenase and result in its degradation with increased 
zinc excretion (100). 
The tendency to low serum zinc concentrations in cir-
rhosis could be regarded as a manifestation of zinc defi-
ciency or it could be the result of low levels of zinc-
carrying protein. 
Bilirubin.inhibits trypsin. chrymotrypsin, pancreatic 
amylase and intestinal alkaline phosphatase (1, 90). Fletman 
suggests bilirubin may do other than chelate zinc and may 
bind protein or inhibit enzyme systems not containing zinc. 
In vitro reversal of bilirubin inhibition can be achieved by 
addition of zinc sulfate. There may be related cause and 
effect in advanced Laennec's cirrhosis with low serum zinc 
levels and increased urinary excretion of zinc and decreased 
levels of hepatic alcohol dehydrogenas.e as have been reported 
above in Iaennec's cirrhosis. Since hyperbilirubinemia is 
oftenpreseI1:t in last stages of post-alcoholic cirrhosis, 
bilirubin may promote excretion of zinc as a bilirubin-zinc 
chelate. This ~yperbilirubinermia has not yet been corre-
lated with zincuria (22). 
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Kahn and co-workers found a tendency to an elevated 
serum zinc in acute hepatitis, which they felt could be a 
result either of release of zinc containing enzyme from 
damaged hepatic cells or of an increase in .zinc binding 
protein owning to its release from the liver, analogous to 
the elevation of serum iron found in aoute hepatitis. Th.ey 
also noticed an abnormally high urinary zinc in half of 
their patients (39)" 
2. Respiratory Distress Syndrome 
An interesting side aspect to zinc-enzyme complex 
interaction may be found in respiratory distress syndrome 
of premature infants and zinc-carbonic anhydrase activity. 
In a study made by Kleinman, .normal, full term, newborn in-
fants had approximately 25% of the carbonic anhydrase acti-
vity of adults. Premature infants without respiratory dis-
tress syndrome, average 13% of adult enzymatic activity and 
those infants with respiratory distress syndrome average 5% 
of adult activity (44). 
The enzymatic activity from premature infants with 
the syndrome were significantly. lower (P le.ss than 0.001) 
than the activities from premature infants without the syn-
drome. See Table (3). 
Newborn babies have blood zinc levels much lower than 
normal adults, but there is no significant difference in 
blood zinc between prematures with and prematures without 
TABLE ). 
COMPARISON OF CARBONIC ANHYDRASE AND ZINC LEVELS 
IN ADULTS, FULL-TERM NEWBORN INFANTS. AND 
PREMATURE INFANTS WITH AND WITHOUT 
RESPIRATORY DISTRESS SYNDROME 
Subjects 
Adults 
Full Term Newborn Infants (40 or more wk gestation) 
Premature infants 
(4.0 wk gestation) without 
respiratory distress syndrome 
Prema ture infan.ts 
(40 wk gestation 




15 4429 ± 100 
76 1100 ± 56.0 
26 584 ± 62.0 
19 2)4 ± 22.6 
Zinc 
pg/ml 
5.45 + 0.18 
1.71 ± 0.06 
1.47 ± 0.07 
1.59 + 0.12 
-
Ratio of Carbonic 
Anhydrase to Zinc 
Concentration 
E.U./)1g 
820.0 + 19.5 
602.5 ± 28.4 
449.5 ± )8.4 
166.1 ± 24.1 
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respiratory distress syndrome. Thus, the enzymatic activity 
per microgram zinc was considerably and significantly lower 
(P<O.OOl) in the premature infants who had the syndrome. 
Kleinman. postulates perhaps one of the carbonic an-
hydrase isoenzymes found at low levels in adult blood are 
at high levels in fetal blood •. Tappan. et al. have shown that 
newborn red blood cells have lower carbonic anhydrase speci-
fic activities than adult red cells (92.). Kleinman further 
suggests that a change of low specific activity to high 
spcific activity carboni.c anhydrase occurs with maturation 
and that this change is slowed or altered in infants with 
the respiratory distress syndrome. 
3. Skin Diseases 
Significantly lowered plasma-zinc concentrations were 
found in patients with psoriasis, othe.r dermatoses and venous 
leg ulcerations. See Table (4). .This finding of abnormally 
low zinc concentrations in the plasma of patients with widely 
differing dermatoses suggests that similar non-specific 
mechanisms may be responsible (24). 
A study done by Kozlowski and associates, unfortun-
ately without statistical controls, found a decrease in the 
zinc content in granUlocytes in patients with advanced skin 
neoplasia, patients with non-specific skin diseases but with 
coexistent internal malignancy. patients with disorders of 








Other Skin Diseases* 
TABLE 4. 
ZINC CONCENTRATIONS IN PATIENTS WITH SKIN DISEASES 
AND IN HEALTHY CON'l'ROIS 
Age (yr) Mean Plasma Zinc 
Number (Mean & Range) (UM) 
41 30.6(19064) 18.1 
20 48.3(19-64) 15.5 
10 35.1{16-63) 16.5 
9 58.4<.,1-61) 15.4 







*DIAGNOSIS, Lichen planus () eczema (3), urticaria (2). sclero4erma (1), pemphi-
goid (1), dermatitis herpetiformis (1), rosacea (1), chronic discoid lupus erythematosis (1). 
P : Significance of difference between test and control means. 
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and erythrodermia (46). 
4. Thermal Burns 
A number of complex metabolic alterations occur as 
the result of full thickness thermal burns. Since approxi-
mately 15% to 20% of the body zinc store is normally found 
within the skin, alterations in zinc metabolism might be ex-
pected to oc.cur in thermal burn patients .. 
Henzel reports a marked body zinc deficit with an 
initial sharp loss of zinc fo.llowing severe thermal burns 
in over forty patients .which la.sts up to 2 to .3 months fol-
lowing the injury before reverting to normal (.31). 
Although the skin is a large reservoir of zinc stor-
age, an alternative reason for the zinc deficit and urinary 
loss must be found beyond stating the thermal burn is the 
etiology of the loss .. since. zinc stores in a full thickness 
burn should theoretically be lost to body use since the burn 
site is no longer blood perfused tissue. This has not yet 
been explored. 
5. Wound Healing 
Acceleration of normal healing by dietary zinc supple-
mentation was accidentally discovered in rats in 1955 by 
Strain (88). It, however, was not until 1967 that successful 
implementation of this finding was reported in humans (70). 
Comparative studies of wound healing were made with 
and without oral zinc sulfate therapy in young human male 
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subjects by measuring the rate of wound healing in wounds 
formed by pilonidol-sinus tract excisions that were allowed 
to heal by secondary intention. The rate of healing was 
determined by measurements of wound. volumes and the number 
of days for complete repair. Patients in. the treated group 
were given 150 mg of elemental zinc daily in the form of 
zinc sulfate in addition to normal diet. Patients in con-
trol group were given no medication other. than normal diet. 
As can be seen in Table (5), the healing rates (mI. per 
day) were nearly three times greater in the treated group 
as compared to the control subjec.tse Al though the experi-
mental group had wound volumes much larger than those in 
the control group, the larger wounds healed 43% sooner with 
orally administered zinc sulfate (71). Although the medi-
cated group healed more rapidly throughout the course of the 
trial, differences were small. during the first fifteen days. 
Of further significance was the difference in wound 
appearance between the two groups. Wounds in the patients 
on zinc sulfate therapy had cleaner, pinker and healthier 
granulations with considerably less purulent exudate than 
wounds in the control group. 
Healing of the granulating wounds could be correlated 
with the concentration of zinc as measured by hair analYSis 
(70) • 
Savlov et al reported in 1962 that radioactive zinc 
TABLE 5. 
COMPARISON OF MEANS OF WOUND VOLUMES. DAYS FOR COMPLETE HEA.LING f 
AND HEALING RATES IN UNTREATED CONTROL PATIENTS AND 
PATIENTS TREATED WI'I'H ZINC SULFATE 
Age Wound Volume Days for 
(yr) hill} Complete Healing 
Mean of Control Patients 25.0 ,32.3 80~1 ± 13.7 
Mean of Treated Patients 24.6 




0.44 ± 0.09 
1.25 ± 0.,30 
p<O.Ol 
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is prefereptially concentrated in healing tissues with the 
peak of activity during the first days after injury. followed 
by gradual decrease. But migration of zinc into wound 
appears to be temporary, since at the time of complete scar-
ring, one hundred days after injury, zinc-65 was not de-
tected in the scar. although the radioisotope was still 
measurable in most tissues (86). 
6. Post-operative Zincuria 
As evidence seems to be accumulating that zinc levels 
may become depressed following significant stress or trauma 
to the biologic organism, man included, surgeons could anti-
cipate the zinc levels to be affected by operative trauma. 
Indeed, this seems to be the case. ' Henzel reports signifi-
cant increases in 24 hour urinary excretion of zinc {which 
reflects acute changes in biologic zinc stores} following 
operative procedures as compared to non-operated controls 
(31). Twenty-four hour urinary excretion of zinc averaged 
0.70 mg/day in the control patients as compared to 1.28 mg/ 
day urinary excretion of zinc during the 20-day postopera-
tive observation period. During the first three postopera-
tive days, daily losses as high as 2.8 mg were recorded per 
the 24-hour collection periods •. 
While postoperative zincuria may not represent a pro-
blem in the normal healthy operative patient, it could 
significantly tilt the balance of zinc stores and cause 
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further depletion in those patients with borderline or sub-
normal stores and cause a tendency to delayed or resistant 
wound healing. 
Consideration should be given to possible zinc sup-
plementation in those patients presenting delayed wound 
healing. 
7. Malignant Diseases 
The status and role zinc may play in neoplastic 
disease either as an etiology. or a theraputic role· remains 
at best sketchy and contradictory with probable multiple 
factors contributing to the confusing state. 
Vallee (103) reports a number of authors who have 
studied zinc in relation to neoplasm. They need not be re-
peated here. 
Erythrocyte zinc levels in myeloproliferative dis-
orders were studied by Valberg who also reports a number of 
other contradictory authors on zinc status in hemoplastic 
diseases (97). Valberg found erythrocyte zinc to be in-
creased above normal in all diseases stUdied, but signifi-
cant to P<0.05 only in. acute leukemia, chronic lymphatic 
leukemia, chronic myelogenous leukemia, Hodgkin's disease. 
and metastalic carcinoma. The greatest increase in mean 
zinc levels was present in chronic myelogenous leukemia 
and Hodgkin's disease, the smallest increase in chronic lym-
phatic leukemic and values intermediate between these results 
were found in acute leukemia, multiple myeloma and in car-
cinoma.. The values in this study are in ac.cord with certain 
previous observations. 
Reduced levels of zinc in granulocytes, in contrast 
to above reported increased erythrocyte zinc levels, are re-
ported by Lawkowicz in patients with wide range of neoplastic 
diseases (47). However, values of granulocyte zinc are re-
ported above normal in chronic lymphatic leukemia. 
Alterations of zinc levels in tissues which presumably 
are not directly participating in the neoplastic process, 
suggests a generalized disorder of zinc metabolism. 
Changes in the activity of certain enzymes have been 
reported in normal and tumor tissues of tumor-bearing animals 
and man (25, 10). Rosoff suggests that since the activity 
of some enzymes depends upon the presence of specific trace 
metals, ce1.~1l:lar derangements resulting in neoplasia may be 
linked with changes in trace metal concentration (82). 
Conjecture concerning the role of zinc in neoplastic 
disease may be premature at this time. 
8. Benign Prostatic Hypertrophy and 
Prostatic Carcinoma 
The in vivo concentration of zinc in human prostatic 
tissue is low in cancer and very high in hyperplasia as com-
pared to normal prostatic tissue (27). This relationship is 
inverse in the in vitro situation. Probably this is an 
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expression of the in vivo saturation of zinc. binding sites 
in the hyperplastic tissue and the relatively unsaturated 
sites in carcinomatous prostatic tissue (28). Gyorkey hypo-
thesizes a zinc-chelation phe.nomenon in BPH and a depression 
of leucine amino peptidase levels, a zinc metallo enzyme in 
prostatic carcinoma (27). 
9. Myocardial Metabolism and 
Cardiovascular Disease 
It has been known for several years that a signifi-
cant decrease in serum zinc is observed in myocardial infarc-
tion with levels averaging 67 ± 13.8 pg zinc per 100 cc as 
compared to 120 ± 19~0 pg zinc per 100 cc in normal control 
patients (109). This is accompanied by changes in a variety 
of enzymes activities and an increase in copper concentration 
(108). 
Following the ingestion of oral alcohol. it has been 
found that zinc is liberated from the myocardium. In peri-
pheral venous studies of alcoholic patients, as zinc level.s 
fell, alcohol dehydrogenase activity rose, suggesting a re~ 
lationship between the changes in zinc and alcohol dehydro-
genase (110). Similar observations have been made in myo-
cardial infarction, where a decrease in plasma zinc concen-
tration is accompanied by an increased activity of malic 
dehydrogenase and lactic dehydrogenase (109). The explana-
tion for the decrease in serum zinc levels and concomittant 
rise in enzyme activity remains unclear, but it does not 
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necessarily indicate an increase in enzyme concentration but 
may be an increase in enzyme activity. 
Hair zinc levels .were observed to be decreased below 
normal patients in patients with proven atherosclerosis. 
The median zinc lev~l of hair was. 62 ppm, which contrasted 
sharply with the provisional normal of 125-150 ppm (89). 
This is consistent with a previous report by Volkov, who 
found a significant decrease in the zinc content of plasma, 
aorta, liver, myocardium and pancreas in a large group of 
patients with atherosclerosis (107). 
10. Zinc Toxicity 
Excess zinc ingestion produces an acute and transi-
tory illness within a few minutes after ingestion with the 
symptoms including malaise, dizziness, tightness of the 
throat, emesis, colic and diarrhea. Usually, this can be 
attributed to the preparation of acid. f'oods (fruits, juices, 
stewed fruits, in galvanized containers, resulting in solu-
bilization of zinc. Treatment is symptomatic and supportive 
(103) • 
Zinc poisoning may occur as a result of three dis-
tinct processes: (1) ingestion of toxic amounts of zinc 
with food or drink; (2) direct skin contact with zinc or 
zinc salts; (3) inhalation of fairly high concentrations of 
freshly formed zinc oxide fumes (103). 
Metal fume fever caused by the inhalation of zinc 
46 
oxide fumes results in fever II malaise., and depression and a 
cough which may become violent enough to induce vomiting, 
excessive salivation, headache, and possible gastrointestinal 
symptoms, though this is disputed. Other aspects observed 
are leukocytosis and chilling about eight hours after ex-
posure (103). 
Zinc apparently antagonizes either the absorption of 
copper from the gastrointestinal tract or the utilization 
of copper within the tissues or both. Under conditions of 
excess zinc, there is a breakdown in the mechanism of hemato-
poiesis and of formation of active. cytochrome oxidase and 
ca talase, for both of. which adequate concentrations of avail-
able copper are necessary (96). 
The level of zinc toxicity has not been determined in 
humans. However, the dose of. the salt, zinc sulfate, causing 
emesis is approximately two grams. Paries in .his wound heal-
ing study, was able to give his patients 220 mg zinc sulfate 
T.I~D. with impunity, in fact, actual beneficial effects (71). 
11. Miscellaneous 
On the basis of some research in zinc deficient chicks, 
an etiology for the development of rheumatoid arthritis could 
be postulated (62). 
Increased amounts of zinc are excreted in the urine 
of patients with acute intermittent porphyria. Fecal and 
urinary porphyrins extracted in this condition apparently are 
zinc complexes. Zinc may act as a detoxirying agent in-
creasing the water solubility and urinary excretion or the 
porphyrins (67). 
Zinc content or mouse dystrophic gastronemious is 
2.2 times that or normal (38). 
Red cell zinc content in patients with pernicious 
anemia is increased over normal. but reverted to normal 
levels arter therapy (99). 
Serum zinc concentrations in acute and chronic in-
rections (pneumonia, bronchitis, erisepelas, pyelonephritis) 
are decreased below the range or normal values and are re-
stored to normal levels with recovery (76) •. 
Urinary zinc excretion is increased in acute rheu-
matic rever (67). 
/ 
Serum zinc levels are increased above normal in 
hyperthyroidism, hypertension, polycythemia vera, and eosino-
philia, and following the administration or adrenaline, 
thyroxine, thyrotropic hormone, theraputic X-irradiation 
and experimentally induced hyperthemia (76). 
Increased urinary excretion of zinc has been round in 
hypertensive patients and during the administration of EDTA. 
The parenteral administration or disodium calcium EDTa to 
hypercholesterolemic patients not only produced a signiri-
cant raIl in serum cholesterollevels~ but induced a simul-
taneous tenfold increase in urinary zinc levels, whereas 
48 
oral administration produced no consistent changes 
in the cholesterol levels but more than a fourfold increase 
in urinary zinc (76). 
Evidence seems to indicate that one of the actions 
of zinc is in the area of protein and nucleic acid synthesis. 
Zinc deficiency in some micro-organisms interferes with the 
synthesis of RNA and thus secondarily inhibits the synthesis 
of DNA and other proteins (77). 
CHAPTER VI 
CONCLUSION 
Much remains to be elucidated concerning the role 
zinc plays in metabolism of humans. The essentiallity of 
zinc for life has been established and that it is active as 
the metal moiety of a number of important enzymes. Zinc 
participates in enzymatic pathways o£ metabolism through its 
close association with these enzymes. 
The metabolic role of zinc is wide reaching. Homeo-
static derangement of zinc produces many different manifes-
tations in plants, animals, and man. 
Although dietary intake and biologic stores of zinc 
may be adequate during health, evidence is accumulating that 
a deficiency may occur rapidly in the chronically ill or 
severely traumatized patient. Possibly, supplemental zinc 
should be provided patients who are nutritionally depleted, 
or who have been subjected to severe trauma. 
To ~ully understand the underlying basis and patho-
logy of zinc deficiency and zinc metabolism, it will require 
continued research to identify the specific areas of meta-
bolic dysfunction and to further delineate observations in 
the composition and struc.ture of. the specific substances 
which function in association with zinc. 
In conclusion, rather than being a micronutrient, or 
"trace element", as zinc is so often labeled, I submit that 
zinc is actually a,major element absolutely essential to 
h~~n life, but is only found in small quantities in the body 
due to the finely tuned role it plays in the overall scheme 
of human metabolism. There are many unanswered questions 
remaining to be studied and answered before the complete 
role of zinc in the body can be fully known. 
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